Home › Funds › BECK MACK & OLIVER LLC › LH
BECK MACK & OLIVER LLC position in LH
LABCORP HOLDINGS INC · Health Care
BECK MACK & OLIVER LLC reported holding 605,243 shares of LH (LABCORP HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$169.5M, representing 3.57% of its reported portfolio and ranking #12 among its reported holdings. BECK MACK & OLIVER LLC has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BECK MACK & OLIVER LLC's LH position evolved
BECK MACK & OLIVER LLC first disclosed a stake in LH in Q3 2023 at 556,273 shares (US$111.8M). The position peaked in Q3 2025 at 610,845 shares, worth US$175.3M. Across 12 filings, BECK MACK & OLIVER LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 605,243 shares valued at US$169.5M — a reduction of -11,388 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 556.27K | $111.84M | New |
| Q4 2023 | 549.25K | $124.84M | Reduce |
| Q1 2024 | 594.60K | $129.90M | Add |
| Q2 2024 | 600.02K | $122.11M | Add |
| Q3 2024 | 605.79K | $135.38M | Add |
| Q4 2024 | 613.03K | $140.58M | Add |
| Q1 2025 | 627.02K | $145.93M | Add |
| Q2 2025 | 614.03K | $161.19M | Reduce |
| Q3 2025 | 610.85K | $175.35M | Reduce |
| Q4 2025 | 627.04K | $157.31M | Add |
| Q1 2026 | 616.63K | $164.52M | Reduce |
| Q2 2026 | 605.24K | $169.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LH and 13F data
LH (LABCORP HOLDINGS INC) is a Health Care company. 30 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.35B), Boston Partners (US$854.2M), Allspring Global Investments Holdings, LLC (US$635.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LH
- VICTORY CAPITAL MANAGEMENT INC 4.84M sh · $1.35B · Q2 2026
- Boston Partners 3.05M sh · $854.20M · Q2 2026
- Allspring Global Investments Holdings, LLC 2.24M sh · $635.03M · Q2 2026
- Select Equity Group, L.P. 1.98M sh · $554.95M · Q2 2026
- Navera Investment Management Ltd. 781.73K sh · $218.92M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 712.30K sh · $199.44M · Q2 2026
- COOKE & BIELER LP 669.18K sh · $187.37M · Q2 2026
More on BECK MACK & OLIVER LLC
FAQ
How long has BECK MACK & OLIVER LLC held LH?
BECK MACK & OLIVER LLC has disclosed LH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BECK MACK & OLIVER LLC's current position in LH?
As of Q2 2026, BECK MACK & OLIVER LLC holds 605.24K shares of LH (LABCORP HOLDINGS INC), valued at $169.47M, representing 3.57% of its reported portfolio and ranking #12.
Has BECK MACK & OLIVER LLC been buying or selling LH?
In the latest 13F filing (Q2 2026), BECK MACK & OLIVER LLC reduced its position in LH. The position peaked in Q3 2025 at 610.85K shares.
Which other funds hold LH?
Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.